Dennis B. Gillings

Co-Founder at GHO Capital Partners LLP

Dennis B. Gillings

Dennis B. Gillings

Co-Founder at GHO Capital Partners LLP

Overview
Career Highlights

IQVIA RDS, Inc. (North Carolina)
Quintiles, Inc. (California)
PharmaBio Development, Inc.

RelSci Relationships

5122

Number of Boards

21

Birthday

1945

Age

76

Number of Awards

6

Relationships
RelSci Relationships are individuals Dennis B. Gillings likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at GHO Capital Partners LLP

Relationship likelihood: Strong

Chairman of the Board, President & Chief Executive Officer at IQVIA Holdings, Inc.

Relationship likelihood: Strong

Executive Chairman at Lightship

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Albany Molecular Research, Inc.

Relationship likelihood: Strong

Co-Founder at GHO Capital Partners LLP

Relationship likelihood: Strong

Chairman at InnerWorkings, Inc.

Relationship likelihood: Strong

Principal at North Bristol Partners LLC

Relationship likelihood: Strong

Managing Director at Bain Capital Partners LLC

Relationship likelihood: Strong

Chief Investment Officer at TPG Capital, LP

Relationship likelihood: Strong

Co-Founder at Vida Ventures LLC

Relationship likelihood: Strong

Paths to Dennis B. Gillings
Potential Connections via
Relationship Science
You
Dennis B. Gillings
Co-Founder at GHO Capital Partners LLP
Family Members
Spouse
Co-Founder at GHO Capital Partners LLP

GHO Capital is an active manager that analyses healthcare trends to invest in mid-market well-established companies with a European presence and global potential.^They focus both on sector specialization and market fundamentals, seeking companies in the PharmaBio, MedTech, Outsourced services and Patient services sectors that offer a combination of double-digit top line growth and international expansion possibilities.^GHO Capital works alongside management teams taking an active role in the company’s growth and development.^

Education
Doctorate Degree

The University of Exeter is a public research university located in South West England, United Kingdom. The university was founded and received its Royal Charter in 1955, although its predecessor institutions, the Royal Albert Memorial College and the University College of the South West of England, were established in 1900 and 1922 respectively. In post-nominals, the University of Exeter is abbreviated as Exon. (from the Latin Exoniensis), and is the suffix given to honorary and academic degrees from the university. The university has three campuses: Streatham; St Luke's (both of which are in Exeter); and Tremough in Cornwall. The university is centred in the city of Exeter, Devon, where it is the principal higher education institution. Streatham is the largest campus containing many of the university's administrative buildings, and is regarded as one of the most beautiful in the country.The Tremough campus is maintained in conjunction with Falmouth University under the Combined Universities in Cornwall (CUC) initiative. The University of Exeter was named The Sunday Times University of the Year in 2013 and was the Times Higher Education University of the Year in 2007. Exeter has maintained a top ten position in the National Student Survey since the survey was launched in 2005. In 2011, it was considered as being one of the top 12 elite universities in the United Kingdom, and has been consistently ranked as one of the top 10 UK universities in recent years.According to the Sunday Times University Guide 2015, Exeter ranks at #7, making it the best university in the South West of England. Exeter University is a member of the Russell Group of leading research-intensive UK universities.The university is also a member of Universities UK, the European University Association, and the Association of Commonwealth Universities and is an accredited institution of the Association of MBAs (AMBA).

Career History
Chief Executive Officer
2016 - Current

PharmaBio Development, Inc., a subsidiary of IQVIA Holdings, Inc., is an American company located in Durham, NC, that operates as an investment company. Dennis B. Gillings is the current CEO, occupying that position since 2016.

Co-Founder
2014 - Current

GHO Capital is an active manager that analyses healthcare trends to invest in mid-market well-established companies with a European presence and global potential.^They focus both on sector specialization and market fundamentals, seeking companies in the PharmaBio, MedTech, Outsourced services and Patient services sectors that offer a combination of double-digit top line growth and international expansion possibilities.^GHO Capital works alongside management teams taking an active role in the company’s growth and development.^

Professional
Current

IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Boards & Committees
Executive Chairman
1982 - 2018

IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC.

Director
Prior

Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC.

Director
1996 - Prior

The Medicines Co We are a global pharmaceutical company focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. In the United States, we have three marketed products, Angiomax® (bivalirudin) for Injection, Cleviprex® (clevidipine) Injectable Emulsion, and Argatroban Injection, 50 mg per 50 mL†. We also have a pipeline of acute and intensive care hospital products in development, including three late-stage development product candidates, cangrelor, oritavancin and MDCO-157, and two early stage development product candidates, MDCO-2010 and MDCO-216. We believe that Angiomax, Cleviprex and our products in development possess favorable attributes that can satisfy unmet medical needs in the acute | intensive care hospital product market and offer, or, in the case of our products in development, have the potential to offer, improved performance to hospital businesses. The Company is publicly traded on the Nasdaq exchange under the ticker symbol MDCO. It was founded in 1996 and employs approximately 425 professionals.

Director
Prior

United Way of Greater Los Angeles is a non-profit organisation. It creates pathways out of poverty for its most vulnerable neighbours. The company ensures long-lasting results through policy-making and influencing local leaders. It fights for the education, housing, and financial stability of everyone in LA County. The company is headquartered in Los Angeles, CA.

Director
Prior

UNC Health Care System owns and operates hospitals. It specializes in cancer care, heart and vascular care, and solid organ transplant. The company was founded in November 01, 1998 and is headquartered in Chapel Hill, NC.

Political Donations
$2,500
2011
$2,400
2010

Former Senator from Nevada

Transactions
Details Hidden

IQVIA Holdings, Inc. issued USD Common Stock

Details Hidden

IQVIA Holdings, Inc. issued USD Common Stock

Details Hidden

IQVIA Holdings, Inc. issued . USD Common Stock

Investments
Details Hidden

Quintiles is the largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 27,000 employees conducting business in approximately 100 countries, we have helped develop or commercialize all of the top 50 best selling drugs on the market. With extensive therapeutic, scientific and analytics expertise, we help biopharmaceutical and health sciences customers navigate the increasingly complex landscape with more predictability to enable better outcomes.

Details Hidden

NovaQuest seeks investment opportunities in middle market companies located in the US with enterprise value of up to $500 million and revenue ranging from $20 - $100 million. The firm targets companies operating in the fields of pharmaceutical, medical technology, life sciences industry,,clinical/outsourcing, provider services, facility services and healthcare IT. The firm provides financing for growth stage capital requirements.

Awards & Honors
2008
Queen Mary University of London
Rank #38
2007
The Chronicle of Philanthropy - Philanthropy 50
2004
Commander of the Most Excellent Order of the British Empire
Events
Speaker
Kawasan Pariwisata Nusa Dua, BTDC Lot N-3-Nusa Dua, Nusa Dua
2013 Forbes Global CEO Conference

Take the lead requires the right vision, strategy, discipline and resilience

Speaker
Sydney, QL, Australia
2010 Forbes Global CEO Conference

The Forbes Global CEO Conference 2010 took place in Sydney on September 28th to the 29th and gathered under one roof some 400 of the world's most influential captains of industry and thought-leaders to share insights on the best strategies to navigate the post-crisis economic landscape and seize new opportunities in volatile times. Hosted by the Australian Government and the New South Wales Government, it held the theme of "Full Sail Ahead", which likens today's business leader to a master mariner, whose challenge is to outwit the forces of uncertain economic conditions and whose determination is to capture new growth prospects through the power of innovation to create a prosperous and sustainable future.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dennis B. Gillings. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dennis B. Gillings's profile does not indicate a business or promotional relationship of any kind between RelSci and Dennis B. Gillings.